XNCR Q1 2022 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$890M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$85M+151.7% YoY

Gross Profit

$38M44.1% margin

Operating Income

$26M31.0% margin

Net Income

$24M27.6% margin

EPS (Diluted)

$0.39

QoQ Revenue Growth

-44.5%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$3M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$858M

Total Liabilities

$95M

Stockholders' Equity

$763M

Cash & Equivalents

$78M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$85M	$34M	+151.7%
Gross Profit	$38M	-$7M	+606.8%
Operating Income	$26M	-$16M	+268.9%
Net Income	$24M	-$2M	+1048.7%

Revenue Segments

Royalties

$79M92%

Milestone

$5M6%

Research collaboration

$2M2%